Scroll Top

Solvay Chimica Italia S.p.A. selects R2’s EMOS® for Rosignano chlor-alkali expansion Project in Italy

Montreal, QC, CanadaR2 announces today that Solvay Chimica Italia S.p.A., a subsidiary of the Solvay Group, has selected R2’s EMOS® (Electrolyser Management & Optimization System) for electrochemical process monitoring of bipolar membrane electrolysers for the chlor-alkali expansion project at its plant in Rosignano, Italy. Solvay Chimica Italia S.p.A. marks the fifth chlor-alkali facility operating under the Solvay Group to implement the EMOS® system (others are located in Rheinberg, Germany; Lillo, Belgium; Bahia Blanca, Argentina and Vinythai, Thailand).

EMOS®‘s high fidelity real-time cell voltage data acquisition and analysis capabilities offers Solvay Chimica Italia S.p.A. unparalleled visibility and reliability for electrolyser process monitoring. Beyond the basic safety (ESD) functions, EMOS® will provide electrolyser condition monitoring for qualitative insight into the useful or remaining operational lifetime or critical components. This generates a precise, proactive approach to electrolyser maintenance and scheduling, which in turn empowers Solvay Chimica Italia S.p.A. to benefit from an increase in operational efficiency and significant reduction in operational costs, helping to ensure that their business objectives are realized.

R2 specializes in the design, development and implementation of solution based analytical advanced monitoring systems (intelligent systems) for industrial process optimization. Precise monitoring of critical process parameters and components helps R2’s clients achieve their business goals by maximizing process efficiency and reducing operating costs. R2 believes in strong relationships with its partners, allowing them to achieve common goals and objectives for the benefit of industrial technological advancement and growth.

SOLVAY is an international chemicals and pharmaceuticals group with headquarters in Brussels, Belgium. It is present in over 50 countries and employs some 30,000 people in its Chemicals, Plastics and Pharmaceuticals activities. Including Fournier Pharma, its 2005 sales amounted to EURO 8.6 billion. Solvay is listed on the Euronext 100 of top European companies. Details are available at www.solvay.com.